Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Current Drug Metabolism
|
March 22, 2017
Towards Predicting the Cytochrome P450 Modulation: From QSAR to Proteochemometric Modeling
Watshara Shoombuatong, Philip Prathipati, Veda Prachayasittikul, et al.
Seminars in Cancer Biology
|
July 5, 2022
Immune checkpoint molecules in neuroblastoma: A clinical perspective
Anup S Pathania, Philip Prathipati, Swati P Murakonda, et al.
Expert Opinion on Drug Discovery
|
March 10, 2017
Exploring the epigenetic drug discovery landscape
Veda Prachayasittikul, Philip Prathipati, Reny Pratiwi, et al.
Molecular Therapy Oncolytics
|
June 6, 2022
miR-15a and miR-15b modulate natural killer and CD8<sup>+</sup>T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma
Anup S Pathania, Philip Prathipati, Omalla A Olwenyi, et al.
Theranostics
|
January 4, 2021
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
Anup S Pathania, Philip Prathipati, Bakrudeen Aa Abdul, et al.
European Journal of Medicinal Chemistry
|
October 19, 2006
alpha-Amino acid derivatives as proton pump inhibitors and potent anti-ulcer agents
Preeti Sharma, Sangeeta Singh, Tanveer I Siddiqui, et al.
Scientific Reports
|
November 27, 2015
Identification of potential inhibitors based on compound proposal contest: Tyrosine-protein kinase Yes as a target
Shuntaro Chiba, Kazuyoshi Ikeda, Takashi Ishida, et al.
Scientific Reports
|
December 22, 2019
A prospective compound screening contest identified broader inhibitors for Sirtuin 1
Shuntaro Chiba, Masahito Ohue, Anastasiia Gryniukova, et al.
F1000Research
|
April 21, 2020
BioHackathon 2015: Semantics of data for life sciences and reproducible research
Rutger A Vos, Toshiaki Katayama, Hiroyuki Mishima, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Current Drug Metabolism
|
March 22, 2017
Towards Predicting the Cytochrome P450 Modulation: From QSAR to Proteochemometric Modeling
Watshara Shoombuatong, Philip Prathipati, Veda Prachayasittikul, et al.
Seminars in Cancer Biology
|
July 5, 2022
Immune checkpoint molecules in neuroblastoma: A clinical perspective
Anup S Pathania, Philip Prathipati, Swati P Murakonda, et al.
Expert Opinion on Drug Discovery
|
March 10, 2017
Exploring the epigenetic drug discovery landscape
Veda Prachayasittikul, Philip Prathipati, Reny Pratiwi, et al.
Molecular Therapy Oncolytics
|
June 6, 2022
miR-15a and miR-15b modulate natural killer and CD8<sup>+</sup>T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma
Anup S Pathania, Philip Prathipati, Omalla A Olwenyi, et al.
Theranostics
|
January 4, 2021
COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
Anup S Pathania, Philip Prathipati, Bakrudeen Aa Abdul, et al.
European Journal of Medicinal Chemistry
|
October 19, 2006
alpha-Amino acid derivatives as proton pump inhibitors and potent anti-ulcer agents
Preeti Sharma, Sangeeta Singh, Tanveer I Siddiqui, et al.
Scientific Reports
|
November 27, 2015
Identification of potential inhibitors based on compound proposal contest: Tyrosine-protein kinase Yes as a target
Shuntaro Chiba, Kazuyoshi Ikeda, Takashi Ishida, et al.
Scientific Reports
|
December 22, 2019
A prospective compound screening contest identified broader inhibitors for Sirtuin 1
Shuntaro Chiba, Masahito Ohue, Anastasiia Gryniukova, et al.
F1000Research
|
April 21, 2020
BioHackathon 2015: Semantics of data for life sciences and reproducible research
Rutger A Vos, Toshiaki Katayama, Hiroyuki Mishima, et al.
Page
of 3